University of Wisconsin–Madison biochemists have developed a new, efficient method that may give first responders, ...

Empyrean Therapeutics acquires TLR-2 antagonist molecule from Eos Therapies to advance and commercialize breakthrough cancer treatment: Boca Raton, Florida Wednesday, November 27, ...

A topical cream to help prevent and treat skin cancers in organ transplant patients is a step closer to development.The world ...

10,808,039) covering ADCs that include auristatin compounds coupled to an antibody via a linker molecule ... It also said the US Patent and Trademark Office has granted a request to review ...

University of Wisconsin–Madison biochemists have developed a new, efficient method that may give first responders, ...

An unusual mode of energy metabolism discovered in a newly identified microbe provides fresh insights into primitive life ...

Add a description, image, and links to the molecule-driver topic page so that developers can more easily learn about it.

Corcept Therapeutics specializes in cortisol-modulating drugs. Click here to read why CORT stock offers investment potential.

A tiny, four-fingered “hand” folded from a single piece of DNA can pick up the virus that causes COVID-19 for highly ...

Contineum Therapeutics, Inc. (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological ...

A small molecule of the naltrexone, an opioid mimic, nestles neatly into a cavity - called a binding site - of a protein ...